Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Animal models for primary sclerosing cholangitis.

J M Vierling1

  • 1Center for Liver Diseases and Transplantation, UCLA School of Medicine, 8635 West Third Street, Los Angeles, CA 90048, USA.

Best Practice & Research. Clinical Gastroenterology
|August 9, 2001
PubMed
Summary

Animal models are crucial for understanding primary sclerosing cholangitis (PSC) pathogenesis. While no perfect model exists, rodent and injury models offer insights into immune responses and biliary fibrosis, guiding future therapeutic development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expert clinical management of autoimmune hepatitis in the real world.

Alimentary pharmacology & therapeutics·2016
Same author

Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy.

Digestive diseases and sciences·2016
Same author

Grazoprevir plus peginterferon and ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection: a randomized trial.

Journal of viral hepatitis·2015
Same author

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II).

Alimentary pharmacology & therapeutics·2015
Same author

Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.

Molecular genetics and metabolism·2013
Same author

Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2007

Area of Science:

  • Immunology
  • Gastroenterology
  • Hepatology

Background:

  • Primary sclerosing cholangitis (PSC) pathogenesis remains unclear in humans.
  • Animal models are essential for studying the immunopathogenesis of biliary diseases.
  • Existing models do not fully replicate all PSC attributes.

Purpose of the Study:

  • To review various animal models used to investigate PSC.
  • To explore insights gained into immunopathogenetic mechanisms of biliary sclerosis.
  • To identify knowledge gaps in PSC etiology and perpetuation.

Main Methods:

  • Review of rodent models induced by bacterial components or colitis.
  • Analysis of models involving direct biliary epithelial, vascular endothelial, or portal venous injury.

Related Experiment Videos

  • Examination of models with toxic, infectious, or intra-luminal biliary tract injury.
  • Consideration of models of extra-hepatic biliary obstruction.

    • Main Results:

    • Rodent models highlight the PSC-inflammatory bowel disease (IBD) association.
    • Direct injury models demonstrate inflammation, chemokines, and cytokines induce biliary sclerosis.
    • Histopathology suggests innate and adaptive immune responses are involved.
    • Some models show anti-neutrophil cytoplasmic antibodies similar to PSC patients.

    Conclusions:

    • Animal models provide valuable insights into PSC immunopathogenesis.
    • The initiating and perpetuating stimuli for peribiliary fibrosis are still unknown.
    • Further research in animal models is critical for developing effective PSC therapies.